相关实验视频

Updated: Jun 25, 2025

The Soft Agar Colony Formation Assay

The Soft Agar Colony Formation Assay

Published on: October 27, 2014

甲基受体2信号调节SLC7A11/xCT在瘤细胞中的表达和活动

Tiziana Pecchillo Cimmino¹, Carolina Punziano¹, Iolanda Panico¹

¹Department of Molecular Medicine and Medical Biotechnology, University of Naples Federico II, 80131 Naples, Italy.

Antioxidants (Basel, Switzerland)

|May 25, 2024

概括

甲基受体2 (FPR2) 激素激活癌细胞中的溶性载体家族7成员11 (SLC7A11/xCT). 这种途径调节谷氨酸合成和脂质过氧化,提供了一个新的癌症治疗点.

科学领域:

生物化学生物化学
细胞生物学细胞生物学
在瘤学瘤学.

背景情况:

癌细胞具有高氧化压力,增加了对谷氨合成的氨酸需求.
溶性载体家族 7 成员 11 (SLC7A11/xCT) 进口囊来产生囊,这对癌细胞存活至关重要.
甲基受体2 (FPR2) 信号影响炎症反应和反应性氧物种的产生.

研究的目的:

研究FPR2激动剂在癌细胞中调节SLC7A11/xCT活性中的作用.
探索FPR2激活对细胞氧化还原平衡和谷氨合成的影响.
通过了解SLC7A11/xCT规则来确定癌症治疗的新型治疗点.

主要方法:

用FPR2激动剂 (WKYMVm和Annexin A1) 刺激CaLu-6癌细胞.
评估SLC7A11/xCT表达和活性.
测量谷氨合成和脂质过氧化水平.
对NRF2核转移和激活的分析.

主要成果:

刺激FPR2激素诱导SLC7A11/xCT的氧化还原调节激活.
激活SLC7A11/xCT促进了谷氨的合成,并防止了脂质过氧化.
FPR2激动剂导致NRF2核转位和激活,表明抗氧化剂反应得到增强.
鉴定出NADPH氧化酶 (NOX) 是该途径的关键调解物.

结论:

FPR2激动剂和NOX信号通路调节SLC7A11/xCT的表达和活性.
这项研究揭示了囊/谷氨酸抗口系统的新型调节途径.
确定的途径代表了人类癌症的潜在治疗目标,特别是那些依赖于高氨酸摄取量的癌症.

关键词:

在NADPH氧化酶.这就是NRF2的NRF2.在 SLC7A11/xCT 中,甲基受体2 甲基受体葡萄糖氨酸氨酸是什么?脂质过氧化过氧化

更多相关视频

Author Spotlight: Assessing the Potential of Circulating Tumor Cells in Leptomeningeal Disease Research

Author Spotlight: Assessing the Potential of Circulating Tumor Cells in Leptomeningeal Disease Research

Published on: March 29, 2024

Screening Peptides that Activate MRGPRX2 using Engineered HEK Cells

Screening Peptides that Activate MRGPRX2 using Engineered HEK Cells

Published on: November 6, 2021

相关概念视频

mTOR Signaling and Cancer Progression

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...

Receptor Downregulation in MVBs

Receptor Downregulation in MVBs

Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR...

Abnormal Proliferation

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...

Mitogens and the Cell Cycle

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...